echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > KKR plans to acquire PRA, a famous cro company, for us $1.3 billion

    KKR plans to acquire PRA, a famous cro company, for us $1.3 billion

    • Last Update: 2013-06-26
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Source: Biovalley 2013-6-26 Kohlberg Kravis Roberts is planning to acquire PRA company through a US $1.3 billion acquisition, a contract research cro company in more than 80 countries around the world, which marks that KKR company will take this opportunity to enter the field of contract research PRA has developed rapidly in the past 12 years, becoming one of the largest companies in cro field Its main business is to undertake some research work for some pharmaceutical enterprises At present, PRA is headquartered in Raleigh, North Carolina, USA it employs more than 4700 people in more than 80 countries PRA has more than 30 years of service experience, has carried out more than 3100 clinical studies, and has made contributions to the successful approval of 40 drugs in multiple treatment fields Kohlberg Kravis Roberts & Co is a private equity investment company headquartered in New York, USA It funds and manages many investment funds, and mainly focuses on leveraged buyouts of mature enterprises KKR's main investment areas are leveraged buyouts and growth capital Since 1977, KKR has invested in more than 160 companies The company has completed more than 400 billion US dollars of private equity transactions and has become the pioneer and leader in the field of leveraged buyouts Original link: http://www.finebiotech.com/story/kkr-scops-global-cro-pra-13b-buyout-deal/2013-06-24
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.